Motheo Tlhagale and Chantal Marx
Puig Brands is one of the most established names in global premium beauty, with origins dating back to 1914 when Antonio Puig Castelló founded the business in Barcelona. From the outset, the company has focused on cosmetics and fragrance, driven by the belief that beauty products could be created with the same artistry and ambition as luxury goods. The business remained family funded through its early decades, expanding under the direction of Antonio Puig and later his four sons, Antonio, Mariano, José María, and Enrique, who gradually assumed leadership from the 1950s onward. Puig established its reputation in the Spanish market through early innovations such as Milady, the first lipstick manufactured in Spain in 1922, and the launch of Agua Lavanda Puig in the 1940s, which became a household fragrance. A new headquarters and factory opened in 1946 in Travessera de Gràcia in Barcelona and served as the company's operational centre for nearly seventy years. International expansion began in 1962, led by Mariano Puig, and by the early 1980s more than half of the company's revenue came from outside Spain, marking a decisive shift from a domestic enterprise toward a global business.
The modern identity of Puig took shape through an acquisition and licensing strategy that accelerated in the late twentieth century. The company developed fragrances for leading fashion houses such as Paco Rabanne and Jean Paul Gaultier, gaining scale and expertise in brand building. Over time Puig transitioned from licensing to ownership, acquiring Jean Paul Gaultier in 2011 and, in the same year, purchasing Carolina Herrera. Earlier, Puig had acquired Myrurgia and its associated fragrance licences, and in 2015 it expanded further into prestige and niche fragrances with the addition of Penhaligon's and L'Artisan Parfumeur. A major strategic shift occurred in 2020 with the acquisition of a majority stake in Charlotte Tilbury, which gave Puig a strong presence in prestige makeup and added a digitally powerful global brand. Subsequent acquisitions strengthened its position across premium beauty categories, including the purchase of Byredo in 2022, and a 65% stake in Dr. Barbara Sturm in 2024.
Today Puig operates a fully-integrated premium personal care model that spans the entire value chain from product development and manufacturing to global branding, distribution, and retail. The company operates seven production facilities across Europe and India and generates revenue across three categories: Fragrance and Fashion, Makeup, and Skincare. Puig has deliberately shifted its mix toward owned brands with superior long-term economics, while maintaining selective licensing partnerships including Christian Louboutin and Adolfo Domínguez. The group also holds minority stakes in sunscreen business ISDIN, Brazilian personal care company, Granado, and textile manufacturer, Sociedad Textil Lonia.
Listed, but still family controlled
Marc Puig Guasch, the founder's grandson, became chief executive in 2003 and later chairman and chief executive, overseeing the company's transition to a publicly traded company. The initial public offering (IPO) in 2024 consisted of a primary offering of €1.25 billion and a ~€1.35 billion secondary offering by the company's controlling shareholder, Exea (the Puig family's holding company).
The listing drew significant attention at the time and was one of the largest in Europe in that year. The shares began trading at €24.50 and the share price peaked at €27.60 in June 2024 but has been in a downward trend since then, reaching a low of €13.35 in October 2025.
The company has two classes of shares, with the family holding almost all Class A shares which carry five votes each, while Class B shares with one vote represents the public float. As of December 2025, Exea held 74.4% of the economic rights in Puig and 93.2% of the voting rights, preserving effective family control.
Luxury fragrance, premium makeup and skincare are structurally strong markets
Puig operates at the intersection of three structurally attractive global consumer categories.
Puig's competitive positioning in fragrance is strong
Fragrance is by far Puig's largest revenue and profit contributor. The company also holds a meaningful market share in the category with an 11.1% global value share in prestige fragrance in FY25, making it the fourth largest player after L'Oreal, LVMH and Estee Lauder.
Industry disruption continues to stem from the rise of independent niche fragrance brands and the rapid growth of e-commerce and direct-to-consumer channels. Puig has responded actively through acquisitions such as Byredo, Penhaligon's, and L'Artisan Parfumeur, and benefits from Charlotte Tilbury's strong digital capabilities, including its successful launch on US Amazon.
At the centre of Puig's competitive moat is a portfolio of culturally entrenched, emotionally resonant brands that command real pricing power and generate durable repeat purchase behaviour. Franchises such as Carolina Herrera's Good Girl, Jean Paul Gaultier's Le Male, and Rabanne's 1 Million hold decades of accumulated brand equity. These three brands are all within the Top ten selective fragrance brands globally.
Financials
Puig delivered one of the strongest growth trajectories in European consumer goods over the last six years, with net revenue rising from €2.0 billion to €5.0 billion between 2019 and 2025, a CAGR of roughly 16%. This growth was driven by both organic momentum and acquisitions. FY25 revenue grew 7.8% on a like-for-like (LFL) basis. Growth was led by Makeup (+13.7%), followed by Skincare (+8.9%) and Fragrance (+6.4%). Guidance for FY26 was not explicit, but the company expects to grow ahead of the premium beauty market on a LFL basis.
The gross profit increased from €1.5 billion in FY19 to €3.8 billion in FY25, with the gross margin improving from 71.9% to 75.1%, reflecting stronger mix, pricing, and supply-chain efficiencies.
In FY25, Puig's cost structure remained heavily focused on brand investment while maintaining disciplined cost control. Advertising & Promotion continued to be the company's largest operating expense, representing 32.7% of revenues, reflecting Puig's commitment to sustaining long-term brand growth. Selling, General & Administrative expenses improved by 37-basis points (bps) compared with FY24, demonstrating effective cost management and operational discipline. Distribution expenses remained flat year-on-year at €232 million, indicating stable logistics and supply-chain costs. Depreciation & Amortisation increased slightly, rising by 22bps as a percentage of revenue to €236 million in FY25.
In FY25, EBITDA increased by 7.8% y/y to €1.045 billion. This translated into an EBITDA margin of 20.7%, up from 20.2% in the prior year and exceeding company guidance by 30bps. The margin expansion was supported by improved operational efficiency, a favourable product mix, and disciplined cost management, particularly through SG&A leverage. By segment, Fragrances & Fashion remained the strongest contributor, generating €859 million in EBITDA with a 19% operating margin. Makeup delivered significant improvement, with EBITDA rising 72% to €135 million from €78 million in FY24, while Skincare recorded a slight decline to €54 million and continued to operate with margins significantly lower than those of the fragrance division.
Puig's return on invested capital (ROIC) has been choppy over the last few years but has consistently been above its weighted average cost of capital (WACC).
Puig demonstrated strong cash generation in 2025, with free cash flow from operations reaching €664 million, resulting in a free cash flow conversion of 64% of adjusted EBITDA. Operational cash flow also improved significantly to €684 million, compared with €549 million in the prior year, supported by stronger underlying cash generation and the absence of IPO-related cash outflows. The company recorded its second consecutive year of enhanced working capital performance, moving closer to normalised operating levels after pandemic-related disruptions. This robust cash generation is expected to support a reduction in net debt to less than 0.5 times EBITDA in 2026, providing capacity for further brand investment and acquisitions.
Puig's capital structure remains conservative and flexible. Net debt decreased to €716 million at the end of 2025, down over €350 million from FY24, representing a net debt-to-EBITDA ratio of 0.7 times. The company is targeting a net debt-to-EBITDA ratio of no more than 2 times to preserve strategic flexibility.
On shareholder returns, Puig maintains a dividend payout ratio of 40% of reported net profits. Dividends paid totalled €238 million in FY25, with a projected increase to €266 million in 2026, reflecting a forward dividend yield of 3.1%.
Investment case
Risks
Consensus considerations
Consensus ratings show 71.5% of analysts holding a BUY recommendation, 19.0% with a HOLD recommendation, and only 9.5% with a SELL recommendation, indicating that most analysts maintain a constructive view of the stock. Over the past year, however, target price expectations have moderated. The 12-month consensus target has fallen from €24.30 in late March 2025 to €20.22 as of 5 March 2026, a reduction of roughly 17%.
Despite these downward revisions, the latest target price still implies about 32% upside from the current level, suggesting that analysts view recent weakness as cyclical or sentiment-driven rather than a sign of structural deterioration.
Valuation
When looking at Puig's valuation multiples relative to industry peers, the company trades at a substantial discount.
This valuation gap has been entrenched since the company's listing despite Puig's exposure to structurally attractive categories, suggesting the market may be pricing in higher execution risk, or lingering post-IPO normalisation effects.
Puig's forward PE over the past 12 months has traded within a relatively stable band, fluctuating around its historical average and staying largely within ±1 standard deviation. After an early peak, the multiple compressed through mid to late 2025 before gradually recovering into early 2026. After a recent global market sell-off, the current valuation sits close to one standard deviation below its long-term average rating. When combined with the observable peer discount, this suggests that Puig is not priced at an extreme level. This leaves room for upside if earnings momentum improves or broader sector sentiment strengthens.
